MyChart
Thanks to the benefits of research, treatment for diseases like hemophilia and sickle cell disease is constantly changing and improving. St. Luke’s offers patients the opportunity to participate in cutting-edge clinical trials through the American Thrombosis & Hemostasis Network (ATHN), as well as multiple pharmaceutical companies.
Investigators
Research Medical Directors
- St. Luke's Cancer Institute research: Peyman Haghighat, MD and Dan Zuckerman, MD
- St. Luke's Cancer Institute pediatric oncology research: Martha Pacheco, MD
Contact Us
If you're interested in hemophilia and blood disorders research at St. Luke’s MSTI, please contact our clinical research manager at (208) 381-2774 or by email.
Support Local Research Opportunities
Your generosity will change lives.
Give to support laboratory research, patient clinical trials and applied research in our community.